B-CELL–TARGETED THERAPY FOR IDIOPATHIC NEPHROTIC SYNDROME: RESULTS OF THE PHASE III, GLOBAL, MULTICENTER INSHORE TRIAL ASSESSING OBINUTUZUMAB VS MYCOPHENOLATE MOFETIL

 

Certificate Output Instructions

For best output, select "Paper Size" as "A4" and "Margin" as "0" or "None".

To save or print to PDF, please select Print Destination > Save as PDF, enable Background Graphics under "More Settings", then click "Save".

 

 

Certificate Background

   

Presented the abstract " "
(Abstract co-author(s):  )

 

 

  Back
E-Poster Presentation

During the congress, E-Posters will be accessible to all participants on the congress website 24/7, as well as in the E-poster stations in the congress center. 

Preparing your E-Poster

Please review the E-Poster format requirements carefully when preparing your E-Poster. Should your E-Poster not meet the mentioned requirements, it may not be displayed as described above.

​E-Poster Submission Deadline

Please prepare and upload your E-Poster no later than March 14, 2026 11.59PM CET. After this date, you will no longer be able to prepare and upload your E-poster and it will not be displayed and accessible on the congress website.​

E-Poster Format Requirements
  • PDF file
  • Layout: Portrait (vertical orientation)
  • One page only (Dim A4: 210 x 297mm or PPT)
  • E-Poster can be prepared in PowerPoint (one (1) PowerPoint slide) but must be saved and submitted as PDF file.
  • File Size: Maximum file size is 2 Megabytes (2 MB)
  • No hyperlinks, animated images, animations, and slide transitions
  • Language: English
  • Include your abstract number
  • E-posters can include QR codes, tables and photos
 
B-CELL–TARGETED THERAPY FOR IDIOPATHIC NEPHROTIC SYNDROME: RESULTS OF THE PHASE III, GLOBAL, MULTICENTER INSHORE TRIAL ASSESSING OBINUTUZUMAB VS MYCOPHENOLATE MOFETIL

Please follow the instructions below to input your abstract title.

Abstract titles should be brief and reflect the content of the abstract.

  • The title will not be accepted if it exceeds 25 words.
  • Type in CAPITAL LETTERS.
  • Lowercase may be used for abbreviations only, for example, mRNA.
Julien
Hogan
Julien Hogan julien.hogan2@aphp.fr Robert Debré Hospital, APHP Department of Pediatric Nephrology Paris France *
Larry A. Greenbaum lgreen6@emory.edu Emory University and Children's Healthcare of Atlanta Division Director of Pediatric Nephrology Atlanta United States -
Kandai Nozu nozu@med.kobe-u.ac.jp Kobe University Graduate School of Medicine Department of Pediatrics Kobe Japan -
Malgorzata Mizerska-Wasiak mmizerska@wum.edu.pl Medical University of Warsaw Department of Pediatrics and Nephrology Warsaw Poland -
Andreia Watanabe a.watanabe@hc.fm.usp.br University of São Paulo School of Medicine Department of Pediatrics São Paulo Brazil -
Andrea Angeletti andreaangeletti@gaslini.org IRCCS Institute Giannina Gaslini Division of Nephrology Genova Italy -
Kenneth Lieberman kenneth.lieberman@hmhn.org Hackensack University Medical Center Department of Pediatrics New Jersey United States -
Jie Ding djnc_5855@126.com Peking University First Hospital Department of Pediatrics Beijing China -
Toru Uchimura toru@yokohama-cu.ac.jp Yokohama City University Medical Center Department of Pediatrics Yokohama Japan -
Franz Schaefer franz.schaefer@med.uni-heidelberg.de University Hospital Heidelberg Division of Pediatric Nephrology Heidelberg Germany -
Theodore A. Omachi omachi.theodore@gene.com Genentech, Inc. Division of Pharmaceuticals South San Francisco United States -
Ben Lanza ben.lanza@roche.com Roche Products Ltd Division of Pharmaceuticals Welwyn Garden City United Kingdom -
Benoît Meger benoit.meger@roche.com F. Hoffmann-La Roche Ltd Division of Pharmaceuticals Basel Switzerland -
Heather Boston heather.boston@roche.com Roche Products Ltd Division of Pharmaceuticals Welwyn Garden City United Kingdom -
Patricia B. Lehane patricia.lehane@roche.com Roche Products Ltd Division of Pharmaceuticals Welwyn Garden City United Kingdom -